Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2025-01-31 Interim / Quarterly Rep…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end Report) for the period January-December 2024. It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary on performance for both the fourth quarter and the full fiscal year. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full annual report (which would be a 10-K equivalent). FY 2024
2025-01-31 Swedish
Preliminärt resultat för fjärde kvartalet
Earnings Release Classification · 1% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and provides preliminary financial results ("Preliminärt resultat") for the fourth quarter (Q4) of the fiscal year, including key figures like revenue (Omsättning) and EBITA, along with commentary from the CEO. It explicitly states that the full report for the fourth quarter will be published later ("Rapporten för det fjärde kvartalet publiceras den 31 januari 2025"). This structure—a brief, preliminary announcement of key financial highlights before the full report release—fits the definition of an Earnings Release (ER). It is not the comprehensive report itself (which would be IR or 10-K), nor is it a transcript (CT) or a general regulatory filing (RNS), as it is specifically focused on earnings highlights. Q4 2024
2025-01-16 Swedish
Ändring av antal aktier och röster i MedCap AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated December 30, 2024, titled "Ändring av antal aktier och röster i MedCap AB" (Change in the number of shares and votes in MedCap AB). It explicitly states that due to the exercise of warrants, the total number of shares and votes has increased, and it provides the new total share capital figures. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not an announcement of a report (RPA/RNS) because it contains the substantive information itself, not just a notice that a report is available.
2024-12-30 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage ('Innehavare', 'Andel', 'Antal aktier') for a specific entity ('Linc AB') in relation to another company ('MedCap AB (publ)'). It specifies the number of shares and voting rights before and after a transaction on a specific date (2024-12-05), resulting in a new holding percentage (19.80882%). This structure is characteristic of mandatory notifications regarding changes in significant share ownership, often triggered when crossing certain thresholds. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be a regulatory filing notification, not a comprehensive report.
2024-12-11 Swedish
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding ('Innehavare', 'Transaktionen', 'Efter transaktionen') for an individual named Bengt Julander concerning MedCap AB (publ). It specifies the number of shares held before and after a transaction, resulting in a new holding percentage (19.80882%). This type of filing, reporting personal share transactions by executives or significant shareholders, directly corresponds to the definition of Director's Dealing or Major Shareholding Notification. Given the context of reporting an individual's transaction crossing or maintaining a threshold, 'Director's Dealing' (DIRS) is the most appropriate fit, although 'Major Shareholding Notification' (MRQ) is also closely related. Since the document explicitly details a transaction by an individual holder, DIRS is selected. The presence of a publication date (2024-12-10) confirms it is a regulatory disclosure, not an announcement of a report.
2024-12-10 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT' (Interim Report) for the period July-September 2024 for MedCap AB. It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary on business performance for the third quarter and the first nine months of the year. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. 9M 2024
2024-10-25 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.